SureTrader Advertisement
Home > Boards > US OTC > Miscellaneous >

EP Global Communications, Inc. (EPGL)

Add EPGL Price Alert      Hide Sticky   Hide Intro
Moderator: Atlanta1, flaflyersfan, integral, Stock Barber, baryoboy
Search This Board:
Last Post: 6/25/2016 1:01:45 PM - Followers: 470 - Board type: Free - Posts Today: 3


About the Company:

EP Global Communications, Inc. is an Advanced Technology Research and Development company for both Medical Devices and Consumer Electronics Devices specializing in Microelectronic Mechanical Systems (MEMS). For more information about the company, please click on the banner above to be directed to the comapny website.

People, Products & Process:
EPGL has assembled an impressive team to propel the company into a bright future and to build shareholder value. Under the leadership of Michael Hayes EPGL underwent debt restructuring, assembly of a new management team, as well as medical and scientific personnel. Mr. Hayes has made it a singular priority to bring aboard only the world’s top professionals in the field of medical sciences to EPGL and thereby build the Company into a major player in the Medical Device Industry over the next several years. He has also committed to prioritizing shareholders and creating significant value for their investment over time. We have seen great evidence of the har work over the last couple years as EPGL has signed Development Agreements with CooperVision, Intel, and AT&T. EPGL is in negotiations to licence technology to CooperVision presently. On April 28th 2015, EPGL disclosed to shareholders that
EPGL and AT&T have created joint Intellectual Properties and are now in the process of procuring those properties. Shareholders can expect developments on this in the near future.

One key team member that was brought on board is David Markus (Vice President, BioMEMS) Developer, As you will see David Markus is a Well Accomplished Engineer.

David T. Markus holds a Ph.D. in Biomedical Engineering and a MS in Electrical Engineering with an emphasis in MEMS Microelectronics and Biomedical. Dr. Markus spent 11 years with Raytheon and holds 8 US patents and has 9 other US Patents Pending. He has been involved in research for several of the world's leading technological institutions, including the Office of Naval Research in Arlington, Virginia, NASA Jet Propulsion Laboratory in Pasadena, CA and he has been published 15 times for various technical conferences. He was a principal investigator on SBIR DARPA Phase I and Phase II, and "Ultraflexible Substrate" for Macroelectronics Program by Dr. Robert Reuss at DARPA. He has been involved in the engineering and the development on seven surgical devices, including devices for Cataract surgery, Intra-Ocular Lens Delivery, Arthroscopy, Endodontic Endoscope, Micro Endoscope and Neural Electrodes. Additionally he was instrumental on developing three medical laboratory devices, including for In-Vitro Fertilization, PCR instrumentation and drug discovery.

The Company has significant know-how and Intellectual Property in the arena of BioMEMS and has invented new device technologies which include, but are not limited to the following:
1. Advanced Power Source for Contact Lenses 11. Advanced TopSpin Platform Technology for Development of Smart Medical Devices
2. Advanced Cell Regeneration Technology to Treat Eye Disease 12. Advanced Device for Steam Cell Treatment Delivery
3. Advanced Cell Regeneration Technology to Treat Hearing Loss 13. Advanced Device for Treatment of Prostate Tumors
4. Advanced Nerve Ablation Device 14. Advanced Endoscopic Device
5. Advanced Epidural Device 15. Advanced Device for Delievery of Micron Sized Drug Payloads
6. New & Promsing Treatment of Restinitis Pigmentosa 16. New & Promising Device for Treatment of Macular Degeneration
7. Advanced Ablation Device for Nerve Treatment of Facial Glabballar Frownig 17. New Advanced Contact Lens Device
8. New Advanced PowerSource for TopSpin Medical Devices 18. Advanced Device For Delivery of Micro Mechanical Devices Into Body
9. Advanced Trigger Point Needle Device 19.  Device for  Advanced Biopsy
10. Advanced Micron Resolution Motor for Smart Medical Devices 20. Real-Time Sensor Technologies for Connectivity to a Global Network  **NEW
21.Real-Time Data Applications for Athletic Teams, Workforces and Military Forces*NEW
EPGL develops advanced technololgies and in negotiations currently to license them to medical device companies and consumer electronic companies.

Contract with CooperVision:
EPGL and CooperVision, Inc. (CooperVision) have signed an exclusive Development Agreement for Advanced Ophthalmic and Medical Technologies. CooperVision is a market leader in the manufacturing and marketing of contact lenses. The Cooper Companies recently completed the acquisition of Sauflon Pharmaceuticals Limited for approximately $1.2 Billion Dollars.

Material Disclosure to Shareholdrs EPGL MED JOINT PATENT VALIDATION
(Includes EPGL MED, COOPERVISION, David T.Markus, Aurthur Back, Luke A.Kilyk, Michael Hayes)

Exclusive Development Agreement Signed with CooperVision, Inc., a Division of The Cooper Companies, Inc. (COO, NYSE)

Contract with Intel:
On September 24, 2014, EP Global Communications, Inc. (EPGL) and Intel Corporation (Intel) executed an Initial Agreement. Additional Agreements are now pending. EPGL management believes that a relationship with Intel will be advantageous to shareholders as the two companies have synergistic goals in various fields. Details of further Agreements will be available upon mutual decision of the parties to disclose them publicly.

On September 24, 2014, EP Global Communications, Inc. (EPGL) and Intel Corporation (Intel) executed an initial Agreement. Additional Agreements are now pending.

Contract with AT&T: 
A new Development Agreement has been executed between AT&T and EPGL on January 4, 2015. As a result of this agreeement Joint Intellectual Properties are now being developed certain data streaming projects in mind. EPGL continues to create new and innovative technologies with large companies
New** EPGL and AT&T have created joint Intellectual Properties and are now in the process of procuring those properties (4/28/15)

EPGL and AT&T Developing Joint Intellectual Properties Companies Sign Development Agreement Resulting in New Inventions in IoT Data Streaming Space

EPGL and AT&T Sign Development Agreement

About EPGL Medical Science's Share Structure :

EPGL has a share structure of 5 billion authorized shares with approximately 4.5 billion shares restricted and a float of approximately 499 million. Following a very successful Reverse Split EPGL has decreased the float by 90% and increased share holder value by over 500% since that time. The company has strongly stated many times that they will not sell shares into the retail market. They are here to build a real company and implement real growth. Since restructuring EPGL has not increased the Float/OS/AS and have given us there word on countless occasions they will not do so. As of Start of January 2015 Pricewaterhouse Coopers and EPGL Reach Agreement to Reduce Outstanding and Authorized Shares.  Reduction of A/S and O/S is currently ongoing and first evidence of EPGL reducing shares will be shown in upcoming Quartley Report  Q3, 2015
** Press Release **  - Pricewaterhouse Coopers and EPGL Reach Agreement to Reduce Outstanding and Authorized Shares Beginning January 2015

** OTC Disclosure ** - Supplemental Information- Retirement of Common Shares by Beneficial Shareholders Commences

Pricewaterhouse Coopers, Corporate Finance and Recovery (Cayman) Ltd.Controlling Agent for:
AJW Qualified Partners, LLC, Controlled by PwC (PricewaterhouseCoopers) Worlds Largest Accounting Firm
1.975 Billion Common Shares
Mr. Michael Hayes
1.975 Billion Common Shares
FLOAT/TRADABLE SHARES : 499 Million ***Unchanged since Restructure in 2012***
Total number of shareholders of record 700 approximate 

The Company leases or utilizes facilities in the following locations

Various California Bay Area Research Facilities Under NDA, David T. Markus, Ph.D.

Irvine, California – Research Facilities, Office

New York University Langone Medical Center, Corey W. Hunter M.D. / Eric Lee M.D.

University of Minnesota, David T. Markus, Ph.D.

University of California at Irvine, David T. Markus, Ph.D.

Dallas and Plano Texas, David T. Markus, Ph.D. **NEW**

Additional Information :
Letter From PricewaterhouseCoopers (Ian Stokoe) Congratulating EPGL on First  Devlopment Agreement (CooperVision)

Follow EPGL on Twitter @epglMED
Follow EPGL on the WEB at



  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
#102976  Sticky Note Link to EP Global Communications 4/28/16 Conference call; flaflyersfan 04/29/16 10:15:58 AM
#97811  Sticky Note EP Global Communications, Inc. Reaches Settlement Agreement with vikingzskillz 02/09/16 02:25:24 PM
#95482  Sticky Note Press releases or other company communication should not Brian !!Retired!! 01/12/16 12:14:18 PM
#106040   Anyone else see there fortune crash yesterday? Happy lukeduke83 06/25/16 01:01:45 PM
#106039   Good week at EPGL. Patent three weeks or lukeduke83 06/25/16 12:47:40 PM
#106038   Cant wait until this takes off baby! I lukeduke83 06/25/16 10:00:06 AM
#106036   $EPGL accumulation continues and close even..... with bids vikingzskillz 06/24/16 07:31:33 PM
#106035   Absolutely Hilarious! ComeWhatMay 06/24/16 06:16:50 PM
#106034   So basically jnj will send you a bumper skorz 06/24/16 05:35:41 PM
#106033   It means that Johnson & Johnson will verify gr8f1 06/24/16 04:31:34 PM
#106032   What does this mean? "Johnson & Johnson Vision Cburg 06/24/16 04:20:45 PM
#106031   very nice indeed was CDEL 1Milly+ on bid support vikingzskillz 06/24/16 04:13:47 PM
#106030   Have to agree Gordon111 06/24/16 03:31:28 PM
#106029   Very nice bid support! ComeWhatMay 06/24/16 03:28:54 PM
#106026   EPGL lukeduke83 06/24/16 03:00:42 PM
#106024   two types of people in this world. ones lukeduke83 06/24/16 02:55:25 PM
#106023   wondering if i should pick up another 100,000 lukeduke83 06/24/16 02:47:39 PM
#106022   Surely Michio Kaku will be the KEYNOTE SPEAKER Donguri 06/24/16 02:27:37 PM
#106021   Epgl is way over value ..........Epgl good as IloveTransformers1984 06/24/16 02:21:20 PM
#106020   EPGL good as "fools" gold.... $epgl$ AJCash 06/24/16 02:20:30 PM
#106019   WDCO a cover for ATDF accumulation reports last vikingzskillz 06/24/16 01:46:43 PM
#106018   Lol, nice... Go $epgl$ vikingzskillz 06/24/16 01:40:39 PM
#106017   EPGL good as gold.... $epgl$ vikingzskillz 06/24/16 01:40:01 PM
#106016   Agree, EPGL has been impressive as a startup, vikingzskillz 06/24/16 01:39:20 PM
#106015   EPGL getting it done, #1 OTC $epgl$ vikingzskillz 06/24/16 01:38:26 PM
#106014   Absolutely right Gman! Carrots make for great H8ster 06/24/16 12:49:09 PM
#106013   Hope everybody is doing alright with the rest H8ster 06/24/16 12:47:02 PM
#106012   Yep eventually we are going to eat so gman22 06/24/16 12:33:36 PM
#106011   oh yes - the "first right of negotiation". Atlanta1 06/24/16 12:28:58 PM
#106010   Statements are proven time and time again gman22 06/24/16 12:26:39 PM
#106009   they have first right of refusal when patents gman22 06/24/16 12:21:39 PM
#106008   no, that's not what it means. Atlanta1 06/24/16 11:47:15 AM
#106007   So if this tweet means that J&J is skorz 06/24/16 11:43:57 AM
#106005   wait - I thought June 21st was the Atlanta1 06/24/16 11:19:19 AM
#106004   July 21, 2016 could possibly be the day Shotime66 06/24/16 11:07:17 AM
#106003   They were smart to get all up into H8ster 06/24/16 11:02:23 AM
#106001   Here's an exchange that very well may have Atlanta1 06/24/16 10:44:01 AM
#106000   Johnson & Johnson Vision Care Inc. - The vikingzskillz 06/24/16 10:43:42 AM
#105999   Tweet "verifying acquisition of $EPGL technology" AJCash 06/24/16 10:41:12 AM
#105997   Check out the new tweet.. Hahha :) cheeva_pitt 06/24/16 10:32:40 AM
#105996   tweet nowy257 06/24/16 10:30:33 AM
#105995   Viking, you said somebody from Facebook group might kura 06/24/16 10:23:00 AM
#105994   Conference 6 pm. on Friday night, WHAT? AJCash 06/24/16 10:04:13 AM
#105993   Or JNJ might say "see ya'". Or they skorz 06/24/16 09:19:09 AM
#105992   huh? not even relevant to the thread. Atlanta1 06/24/16 08:55:26 AM
#105991   JNJ just might buy EPGL out... vikingzskillz 06/24/16 08:54:29 AM
#105990   Kinda like it was said COo didn't exist, vikingzskillz 06/24/16 08:53:07 AM
#105989   exactly. it's a preposterous claim. Atlanta1 06/24/16 08:52:10 AM
#105988   no, they didn't. Atlanta1 06/24/16 08:51:13 AM
#105987   So your saying J&J sign deals with so vikingzskillz 06/24/16 08:46:45 AM
#105986   Why would the USPTO care to read anyone's integral 06/24/16 08:43:45 AM
#105985   JNJ replaced CooperVision, great isn't it!! vikingzskillz 06/24/16 08:41:45 AM
#105984   CooperVision had no problem with them, AT&T has Atlanta1 06/24/16 08:39:45 AM